Insmed (INSM) director sells 10K shares at $195.87 in Form 4
Insmed Inc. (INSM) reported an insider stock sale by a company director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Insmed Inc. (INSM) reported an insider stock sale by a company director. On 11/14/2025, the director sold 10,000 shares of common stock at a price of $195.87 per share, according to a Form 4 filing. After this transaction, the director continues to hold 63,729 shares directly. This filing simply records a change in the director’s personal holdings and does not, by itself, change the company’s operations or financial results.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $195.87 | $1.96M |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Insmed (INSM) report in this Form 4?
When did the Insmed (INSM) insider sale take place?
What is the reporting person’s relationship to Insmed (INSM)?
Does this Insmed (INSM) Form 4 involve any derivative securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.